Literature DB >> 428710

Bilary lipid metabolism in obesity. Effects of bile acid feeding before and during weight reduction.

H Y Mok, K von Bergmann, J R Crouse, S M Grundy.   

Abstract

Obese subjects are prone to supersaturated bile, which is maintained or increased during weight loss. In this report, two related studies were carried out on obese subjects to investigate effects of bile acid feeding on biliary lipid metabolism before and during weight reduction. In one study, chenodeoxycholic acid (CDCA), 750 mg/day, was given to 12 obese subjects during weight maintenance (1st mo) and during weight reduction (2nd mo). In the second study, effects of two bile acid preparations, CDCA and Bilron (containing mostly cholic acid and deoxycholic acid), randomly administered, were compared in another 12 obese subjects undergoing weight reduction. The results show that obese subjects had large pools of bile acids during weight maintenance which decreased on caloric restriction (1,000 kcal/day). CDCA increased pool size only modestly during weight maintenance, from 3,536 +/- 1,267 (SD) mg to 4,735 +/- 1,434 mg. Both CDCA and Bilron markedly reexpanded the contracted pool of bile acids in obese subjects on weight reduction. However, significantly reduced saturation of bile occurred only in those on CDCA and weight reductions, whereas supersaturation was unaltered when weight was maintained constant in these patients, or when Bilron was given. No significant side effects were noted during bile acid feeding for any of the subjects. Thus, CDCA given to obese subjects on weight reduction will reduce bile saturation and could protect against gallstones.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 428710

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Prevalence and treatment of gall stones after gastric bypass surgery for morbid obesity.

Authors:  D A Wattchow; J C Hall; M J Whiting; B Bradley; J Iannos; J M Watts
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-05

Review 2.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

3.  Similarity in gallstone formation from 900 kcal/day diets containing 16 g vs 30 g of daily fat: evidence that fat restriction is not the main culprit of cholelithiasis during rapid weight reduction.

Authors:  W C Vezina; D M Grace; L C Hutton; M H Alfieri; P R Colby; D B Downey; R J Vanderwerf; N F White; R P Ward
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

Review 4.  Women and obesity. Learning to live with it.

Authors:  D Ciliska
Journal:  Can Fam Physician       Date:  1993-01       Impact factor: 3.275

5.  The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).

Authors:  S M Grundy; S P Lan; J Lachin
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

Review 6.  Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature.

Authors:  Timothy E Sweeney; John M Morton
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-08-12       Impact factor: 3.043

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.